Mechanisms and Management of Dysmenorrhea: Current Understanding and Novel Therapeutic Directions

Ruohan Zhang

doi:10.54254/2753-8818/2025.21683

Research Article

Open access

Published on 31 March 2025

Download pdf

Zhang,R. (2025). Mechanisms and Management of Dysmenorrhea: Current Understanding and Novel Therapeutic Directions. Theoretical and Natural Science,99,28-35.

Export citation

Mechanisms and Management of Dysmenorrhea: Current Understanding and Novel Therapeutic Directions

Ruohan Zhang *^,1,

¹ The High School Affiliated to Renmin University of China, Beijing, China

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/2025.21683

Abstract

Dysmenorrhea significantly impacts the quality of life and health of many women worldwide, with primary dysmenorrhea being a major component. Primary dysmenorrhea is primarily driven by the excessive production of prostaglandins, which are responsible for regulating uterine contractions and the shedding of the endometrium. While prostaglandins are essential for normal bodily functions, their overproduction during menstruation leads to severe cramps and considerable pain. In this review, we examine the key biological pathways that contribute to dysmenorrhea, along with the mechanisms behind current treatment strategies and their effectiveness. Based on the current understanding of dysmenorrhea’s underlying mechanisms and the insights gained from the reviewing process, we propose potential new drug targets for treatment. Furthermore, we offer comprehensive recommendations for managing dysmenorrhea, combining the results of the further analysis of our previous survey data. We also emphasize the significance of interdisciplinary research, with collaboration across various fields to enhance our understanding and improve the comprehensive management of dysmenorrhea, ultimately benefiting women's health and well-being more effectively.

Keywords

Dysmenorrhea, Novel Therapeutic Targets, Women’s Health

View pdf

References

[1]. Hillard, P. J. A. (2014). Menstruation in adolescents: What's normal, what's not. Annals of the New York Academy of Sciences, 1308(1), 21–29. DOI: 10.1196/annals.1429.022

[2]. Iacovides, S., Avidon, I., & Baker, F. C. (2015). What we know about primary dysmenorrhea today: A critical review. Human Reproduction Update, 21(6), 762–778. DOI: 10.1093/humupd/dmv039

[3]. Chen, C. X., Draucker, C. B., & Carpenter, J. S. (2018). What women say about their dysmenorrhea: A qualitative thematic analysis. BMC Women's Health, 18, Article 47. DOI: 10.1186/s12905-018-0538-8

[4]. Balachandren, N., & Davies, L. (2023). Dysmenorrhea. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK560834/

[5]. Christensen, K. (2024). Dysmenorrhea: An update on primary healthcare management. Australian Journal of General Practice, 53(1–2). doi: 10.31128/AJGP/04-23-6815

[6]. Dawood, M. Y. (2006). Primary dysmenorrhea: Advances in pathogenesis and management. Obstetrics & Gynecology, 108(2), 428–441. DOI: 10.1097/01.AOG.0000230214.26638.0c

[7]. Tadesse, M., Kassa, A., Muluneh, A. A., & Altaye, G. (2021). Prevalence of dysmenorrhoea associated risk factors and its relationship with academic performance among graduating female university students in Ethiopia: a cross-sectional study. BMJ Open, 11(3), e043814. doi: 10.1136/bmjopen-2020-043814

[8]. Nie, W., Xu, P., Hao, C., Chen, Y., Yin, Y., & Wang, L. (2020). Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea: A network meta-analysis. Medicine, 99(19), e19881. doi: 10.1097/MD.0000000000019881

[9]. Oladosu, F. A., Tu, F. F., & Hellman, K. M. (2018). Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: Epidemiology, causes, and treatment. American Journal of Obstetrics and Gynecology, 218(4), 390–400. PMCID: PMC5839921 NIHMSID: NIHMS904572 PMID: 28888592

[10]. Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020). Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol, 180, 114147. https://doi.org/10.1016/j.bcp.2020.114147

[11]. Owen, P. R. (1984). Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. American Journal of Obstetrics and Gynecology, 148(1), 96–103. DOI: 10.1016/s0002-9378(84)80039-3

[12]. Hijos-Mallada, G., Sostres, C., & Gomollón, F. (2022). NSAIDs, gastrointestinal toxicity and inflammatory bowel disease. Gastroenterol Hepatol, 45(3), 215-222. https://doi.org/10.1016/j.gastrohep.2021.06.003 (AINE, toxicidad gastrointestinal y enfermedad inflamatoria intestinal.)

[13]. Pepin, É., Dehboneh, S. S., Raguema, N., Esfandarani, M. T., & Lavoie, J. L. (2017). Role of the Renin-Angiotensin System in Healthy and Pathological Pregnancies. IntechOpen. DOI: 10.5772/66748

[14]. Haroun, H. S. W. (2016). Reproductive cycles in females. MOJ Womens Health, 2(2), 62–63. DOI: 10.15406/mojwh.2016.02.00028

[15]. Ylikorkala, O., & Dawood, M. Y. (1978). New concepts in dysmenorrhea. American Journal of Obstetrics and Gynecology, 130(7), 833–847. DOI: 10.1016/0002-9378(78)90019-4

[16]. Rosenwaks, Z., & Seegar-Jones, G. (1980). Menstrual pain: Its origin and pathogenesis. The Journal of Reproductive Medicine, 25(4 Suppl), 207–212. PMID: 7001019

[17]. Maia H, Maltez A, Studard E, Zausner B, Athayde C, Coutinho E. Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol. 2005;21(1):57–61. doi: 10.1080/09513590500099602

[18]. Funk, C. D. (2023). Thromboxane A2. In StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK539817/

[19]. Nakanishi, M., & Rosenberg, D. W. (2013). Multifaceted roles of PGE₂in inflammation and cancer. Seminars in Immunopathology, 35(2), 123–137. PMCID: PMC3568185 NIHMSID: NIHMS409312 PMID: 22996682

[20]. Li, X., Zhang, X., Wen, X., Zhang, D., Qu, C., Miao, X., Zhang, W., Zhang, R., Liu, G., Xiao, P., Sun, J.-P., & Gong, W. (2024). Structural basis for ligand recognition and activation of the prostanoid receptors. Cell Reports, 43(3), 113893. https://doi.org/10.1016/j.celrep.2024.113893

[21]. Word, R. A., Kamm, K. E., & Casey, M. L. (1992). Contractile effects of prostaglandins, oxytocin, and endothelin-1 in human myometrium in vitro: Refractoriness of myometrial tissue of pregnant women to prostaglandins E2 and F2 alpha. The Journal of Clinical Endocrinology & Metabolism, 75(4), 1027–1032. DOI: 10.1210/jcem.75.4.1400867

[22]. Qu, C., et al. (2021). Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E2 receptor EP2 subtype. Science Advances, 7, eabf1268. https://doi.org/10.1126/sciadv.abf1268

[23]. Dawood, M. Y. (1981). Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations. Drugs, 22(1), 42–56. DOI: 10.2165/00003495-198122010-00003

[24]. Zhang, R. (2024). Breaking Myths and Improving Awareness: Insights from a Survey on Menstrual Pain and Health. Theoretical and Natural Science (TNS), 61, 163–172. DOI: 10.54254/2753-8818/61/20241513

[25]. Akin, M. D., Price, W., Rodriguez, G. Jr., Erasala, G., Hurley, G., & Smith, R. P. (2004). Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhea. Journal of Reproductive Medicine, 49(9), 739–745. PMID: 15493566

[26]. Matthewman, G., Lee, A., Kaur, J. G., & Daley, A. J. (2018). Physical activity for primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials. American Journal of Obstetrics and Gynecology, 219(3), 255.e1–255.e20. DOI: 10.1016/j.ajog.2018.04.001

[27]. Hosseinlou, A., Alinejad, V., Alinejad, M., & Aghakhani, N. (2014). The effects of fish oil capsules and vitamin B1 tablets on duration and severity of dysmenorrhea in students of high school in Urmia-Iran. Global Journal of Health Science, 6(7 Spec No), 124–129. doi: 10.5539/gjhs.v6n7p124

[28]. Matsas, A., Sachinidis, A., Lamprinou, M., Stamoula, E., & Christopoulos, P. (2023). Vitamin effects in primary dysmenorrhea. Life, 13(6), 1308. https://doi.org/10.3390/life13061308

[29]. Wiggleton-Little, J. (2024). "Just" a painful period: A philosophical perspective review of the dismissal of menstrual pain. Women's Health, 20, 17455057241255646. PMCID: PMC11113068 PMID: 38773901

[30]. Mukanga, B., Mwila, N., Nyirenda, H. T., & Daka, V. (2023). Perspectives on the side effects of hormonal contraceptives among women of reproductive age in Kitwe district of Zambia: A qualitative explorative study. BMC Women's Health, 23, Article 436. PMCID: PMC10439553 PMID: 37596577

[31]. Torres-de la Roche, L. A., Acevedo-Mesa, A., Lizarazo, I. L., Devassy, R., Becker, S., Krentel, H., & De Wilde, R. L. (2023). Hormonal contraception and the risk of breast cancer in women of reproductive age: A meta-analysis. Cancers, 15(23), 5624. PMCID: PMC10705112 PMID: 38067328

[32]. Smith, R. P. (2018). The role of prostaglandins in dysmenorrhea and menorrhagia. In Dysmenorrhea and Menorrhagia (pp. 75–88). Springer. Retrieved from https://link.springer.com/chapter/10.1007/978-3-319-71964-1_6

[33]. Ju, H., Jones, M., & Mishra, G. (2014). The prevalence and risk factors of dysmenorrhea. Epidemiologic Reviews, 36(1), 104–113. DOI: 10.1093/epirev/mxt009

Cite this article

Zhang,R. (2025). Mechanisms and Management of Dysmenorrhea: Current Understanding and Novel Therapeutic Directions. Theoretical and Natural Science,99,28-35.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 5th International Conference on Biological Engineering and Medical Science

Conference website: https://2025.icbiomed.org/

ISBN：978-1-80590-007-8(Print) / 978-1-80590-008-5(Online)

Conference date: 17 October 2025

Editor：

Series: Theoretical and Natural Science

Volume number: Vol.99

ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).